References
[1] E. Dahlström, E. F. Viberg, "Knowledge about Hepatitis B and Attitudes Towards Hepatitis B among Vietnamese University Students in Ho Chi Minh City", Thesis in Caring Sciences, Vietnam, pp.1-39, 2013.
[2] C.M. Weinbaum, E.E. Mast, J.W. Ward, "Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection", Hepatology, Vol.49, Issue.5, pp.35-44, 2009.
[3] J. Chao, E.T. Chang, S.K.S. So, "Hepatitis B and Liver Cancer Knowledge and Practices among Healthcare and Public Health Professionals in China: A Cross-sectional Sudy", Bio Med Central Public Health, Vol.10, Issue.98, pp.1-11, 2010.
[4] C. Niederhauser, T. B. Mansouri, M. Graziani, M. Stolz, C. Tinguely, P. Schneider, "Blood Donor Screening: How to Decrease the Risk of Transfusion?transmitted Hepatitis B Virus", Swiss Med Wkly, Vol.138, pp.134?41, 2008.
[5] G.M. Calderón, F. González-Velázquez , C.R. González-Bonilla, B. Novelo-Garza, J.J. Terrazas , M.L. Martínez-Rodríguez, "Prevalence and Risk Factors of Hepatitis C Virus, Hepatitis B Virus, and Human Immunodeficiency Virus in Multiply Transfused Recipients in Mexico", Transfusion, Vol.49, pp.2200?2207, 2009.
[6] S.A. Kafi-abad, H. Rezvan, H. Abolghasemi, A. Talebian, "Prevalence and Trends of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus among Blood Donors in Iran, 2004 through 2007", Transfusion, Vol.49, Issue.2214-2220, 2009.
[7] Y.H. Shi, "Correlation Between Hepatitis B virus Genotypes and Clinical Outcomes", Journal of Infectious Disease, Vol.65, pp.476?482. 2012.
[8] S.O. Odemuyiwa, M.N. Mulders, O.L. Oyedele, S.O. Ola, G.N. Odaibo, D.O. Olaleye, "Phylogenetic Analysis of New Hepatitis B Virus Isolates from Nigeria Supports Endemicity of Genotype E in West Africa", Journal of Medical Virology, Vol.65, pp.463-469, 2001.
[9] D. Lavanchy, ?Hepatitis B Virus Epidemiology, Disease Burden, Treatment, and Current and Emerging Prevention and Control Measures,? Journal of Viral Hepatitis, Vol.11, No.2, pp.97-107, 2004.
[10] J.Z. Saidu, P.O. Oyedoh, G. Ngagwaonye, "Hepatitis B Surface Antibody (HBSAB) and Co-Inffection with Malaria Parasite in Benin City, Edo State, Nigeria", International Journal of Scientific Research in Biological Sciences, Vol.7, Issue.2, pp.158-162, 2020.
[11] E.D. Gurmu, B.K. Bole, P.R. Koya, E.D. Gurmu, B.K. Bole, P.R. Koya, "A Mathematical Model for Co-infection of HPV and HSV-II with Drug Resistance Compartment", International Journal of Scientific Research in Mathematical and Statistical Sciences, Vol.7, Issue.2, pp.34-46, 2020.
[12] P. Van Damme, K. Van Herck, ?A review of the long-term protection after Hepatitis A and B vaccination,? Travel Medicine and Infectious Disease, Vol.5, No.2, pp.79-84, 2007.
[13] S. Lok, B. J. McMahon, ?Chronic Hepatitis B,? The New England Journal of Medicine, Vol.346, No.22, pp.1682-1683, 2002.
[14] World Health Organization. "Department of Communicable Disease Surveillance and Response ", Unpublished, 2009.
[15] World Health Organization. "Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Post Exposure Prophylaxis", Unpublished, 2011.
[16] A. Kay, F. Zoulim, ?Hepatitis B Virus Genetic Variability and Evolution,? Virus Research, Vol.127, No.2, pp.164-176. 2018.
[17] J. Mokaya, A.L. McNaughton, L. Burbridge, T. Maponga, G. O?Hara, M. Andersson, "A Blind Spot Confronting the Stigma of Hepatitis B Virus (HBV) Infection?A Systematic Review", Wellcome Open Res. Vol.3, p.29. 2018.
[18] G.A. O?Hara, A.L. McNaughton, T. Maponga, P. Jooste, P. Ocama, R. Chilengi, "Hepatitis B Virus Infection as a Neglected Tropical Disease", PLos Negl Trop Dis, Vol.11, pp.42-58, 2017.
[19] M.M. Alam, S.Z. Zaidi, S.A. Malik, A. Naeem, S. Shaukat, S. Sharif, M. Angez, A. Khan, J.A. Butt, "Serology Based Disease Status of Pakistani Population Infected with Hepatitis B virus", BMC Infect Dis, Vol.7, p.64, 2007.
[20] R. Zhu, H. Zhang, H. Yu, H. Li, Y.Q. Ling, X.Q. Hu, H.G Zhu, "Hepatitis B Virus Mutations Associated with in Situ Expression of Hepatitis B Core Antigen, Viral Load and Prognosis in Chronic Hepatitis B Patients", Pathol Res Pract, Vol.204, pp.731-742, 2008.
[21] D. Glebe, S. Urban, ?Viral and Cellular Determinants Involved in Hepadnaviral Entry,? World Journal of Gastroenterology, Vol.13, No.1, pp.22-38, 2007.
[22] A. Salisu, M. D. Muktar, A. I. Salisu, Y. Abdulhadi, M. Umar, ?A Survey on the Prevalence of Hepatitis B Virus and Predisposing Factors among Blood Donors in two General Hospitals in Jigawa State Nigeria,? International Journal of Health and Medical Sciences, Vol.3, No.2, pp.29-37, 2017.
[23] O. A. Ejele, C. A. Nwauche, O. Erhabor, ?The Prevalence of Hepatitis B Surface Antigenaemia in HIV Positive Patients in the Niger Delta Nigeria,? Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria, Vol.13, No.2, pp.175-179, 2003.
[24] O. M. David, A. O. Oluduro, A. B. Ariyo, D. Ayeni, O. Famurewa, ?Sero-epidemiological Survey of Hepatitis B Surface Antigenaemia in Children and Adolescents in Ekiti State, Nigeria,? Journal of Public Health and Epidemiology, Vol.5, No.1, pp.11-14, 2013.
[25] J. H. Kao, D. S. Chen, ?Global Control of Hepatitis B Virus Infection,? The Lancet Infectious Diseases, Vol.2, No.7, pp.395-403, 2002.
[26] L. A. Eller, M. A. Eller, B. Ouma, P. Kataaha, D. Kyabaggu, R. Tumusiime, H. Kibuuka, ?Reference Intervals in Healthy Adult Ugandan Blood Donors and their Impact on Conducting International Vaccine Trials,? Plos One, Vol.3, No.12, pp.1-6, 2008.
[27] C. O. Imarengiaye, M. E. Enosolease, P. E. Iribhogbe, A. E. Ehigiegba, ?Risk of Transfusion-transmitted Hepatitis C Virus in a Tertiary Hospital in Nigeria,? Public Health, Vol.120, No.3, pp.274-278, 2006.
[28] S. I. Gan, S. M. Devlin, N.W. Scott-Douglas, K.W. Burak, ?Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection,? Canadian Journal of Gastroenterology and Hepatology, Vol.19, No. 10, pp.625-629, 2005.